Chart
We summarize the week's scientific breakthroughs every Thursday.
- Health & Medicine
A new drug shows promise for hard-to-treat high blood pressure
Results from a large trial suggest baxdrostat could provide a new option for people whose blood pressure remains high despite standard treatment.
- Health & Medicine
COVID-19 is still a threat, but getting a vaccine is harder for many people
Vaccination is still important to ward off the worst of the coronavirus. Three experts discuss the concerns with restricting access.
- Earth
20 years after Hurricane Katrina, is the U.S. better prepared?
Hurricane forecasts have improved since Katrina, but risks from climate change and budget cuts loom.
- Life
Squashing the spotted lanternfly problem may require enlisting other species
The invasive spotted lanternfly has spread to 17 states and can threaten vineyards. But bats, fungi, dogs and even trees may help control them.
- Health & Medicine
U.S. measles outbreaks may end a hard-won victory over the virus
Dropping vaccination rates and changes in U.S. vaccine policy have public health experts concerned that annual measles outbreaks could become more frequent.
- Health & Medicine
A genetic test may predict which weight loss drugs work best for patients
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
- Health & Medicine
Biden’s prostate cancer is incurable, but it is treatable
Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.
- Health & Medicine
An at-home cervical cancer screening device was OK‘d by the FDA
The Teal Wand, an at-home HPV testing device that could replace a Pap smear, could broaden access to cervical cancer screening.
- Science & Society
$1.8 billion in NIH grant cuts hit minority health research the hardest
News of NIH funding cuts have trickled out in recent months. A new study tallies what’s been terminated.
- Health & Medicine
Clinical trials face uncertain futures amid Trump cuts
The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.
- Paleontology
Could Spinosaurus swim? The fierce dinosaur ignites debate
Researchers are still divided about whether Spinosaurus was a swimmer or a wader. What’s clear is that confirming the first swimming dinosaur would be a game-changer.
- Health & Medicine
A shadowy market for weight-loss drugs has emerged online
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
